DERMATOLOGY BIZ
Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaThe company has issued a letter to the Taro board with a proposal containing a non-binding indication of interest to acquire all of the out...
Taro stake buyout to help operate its dermatology biz profitably amid enhanced competition: Sun PharmaSun Pharma is looking to fully acquire its Israel-based unit Taro Pharmaceutical Industries in order to integrate the dermatology business ...
WASME Announces Winners of Global Icon Awards 2022
Paytm’s mega IPO gets all-clear; Google’s fee cut a ‘distraction’Paytm is on track to become a publicly traded company by mid-November. Earlier today, the Securities and Exchange Bureau of India (Sebi) ga...- Neutral Glenmark Pharmaceuticals with a target of Rs 960: UBSExpect base US biz to improve as a result of recent launches in dermatology. UBS has forecast a 33% EPS CAGR over FY16-18E for Glenmark Pha...
Load More